Business Context and Reporting Period
This Form 8-K is a current report filed by OncoCyte Corporation (noted as Insight Molecular Diagnostics Inc. in metadata) on March 30, 2016. The filing serves to announce the company's financial results for the fourth quarter and the full fiscal year ended December 31, 2015. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is incorporated by reference but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the body text. It directs readers to the attached press release for the announcement of results for the fourth quarter and fiscal year 2015.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing includes a standard disclaimer that statements containing words such as "may," "will," "believes," or "expects" are forward-looking and subject to risks.
- Risk Factors: The company directs investors to its Form 10 filed with the SEC under the heading "Risk Factors" for additional details on factors that could cause actual results to differ materially from anticipated results.
- Outlook: No specific guidance or outlook figures are provided in this text; the company disclaims any obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing the attached Exhibit 99.1 (Press Release dated March 30, 2016).
- Confirm the company's current legal name and status, as the metadata lists "Insight Molecular Diagnostics Inc." while the filing header lists "OncoCyte Corporation."
- Review the company's most recent Form 10 to understand the specific "Risk Factors" referenced in the forward-looking statements disclaimer.
- Check for any subsequent filings that may update the financial results or forward-looking statements made on March 30, 2016.